Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-25 @ 2:20 AM
NCT ID:
NCT00477334
Eligibility Criteria:
Inclusion Criteria:
* Black men or women 18 years or older
* History of recurrent genital herpes with at least 4 recurrences in preceding 12 months or in preceding 12 months prior to using suppressive antiviral therapy
* Documented herpes simplex virus type 2 (HSV-2) seropositivity
* Willingness to discontinue suppressive therapy during study, if applicable
* Willingness and ability to comply with the study protocol
Exclusion Criteria:
* Pregnant or breastfeeding women
* Women of childbearing potential not using accepted methods of contraception
* Hypersensitivity to famciclovir or drugs with similar chemical structures
* Renal dysfunction
* Known or suspected to have decompensated liver disease
* Known to have gastrointestinal malabsorption
* Known to be immunocompromised
* Known to be hypersensitive to ingredients in study medication
* Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00477334
Study Brief:
Protocol Section:
NCT00477334